Long-term safety follow-up for Parkinson's study participants
Part of Brain & nervous system clinical trials.
This study follows up with people who previously received an experimental treatment called RGL-193 for Parkinson's disease. It aims to check how safe and effective the treatment is over a longer period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in an earlier RGL-193 study and received the treatment.
- You must agree to join this follow-up study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who previously received IPS101A, an experimental gene therapy treatment for severe Parkinson's disease. Researchers want to check how you're doing over time and gather information about the treatment's long-term effects.
This trial is for people with Parkinson's disease or multiple system atrophy (parkinsonian type) who took part in an earlier AB-1005 study. It will continue to monitor your health over time to learn more about the treatment's long-term effects.
This study tests an experimental drug called LY3962681 in two groups: healthy volunteers and people with Parkinson's disease. The goal is to see if the drug is safe and how the body handles it, which may lead to future treatments for Parkinson's.
This trial tests an experimental drug called RO7568282 to see if it is safe and can help with early Parkinson's disease symptoms. It is for people who have been taking a stable dose of levodopa alone for at least two months.
This study follows people with Parkinson's disease who still have movement symptoms despite taking medication. It aims to understand how the disease changes over time, which could help improve future treatments.
This study follows people with Parkinson's disease who are starting a second-line treatment — like deep brain stimulation, an apomorphine pump, or a duodopa pump — to see how these treatments work over time and how they affect daily life.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.